Viorel Buculei is the Director of Quality Control at Jubilant Radiopharma and a pharmaceutical quality professional with more than 20 years of industry experience. Throughout his career, he has been dedicated to advancing quality excellence within complex GMP-regulated environments, developing extensive expertise in Quality Control, Quality Assurance, Quality Systems, Compliance, Validation and Quality Risk Management.

Having held senior leadership roles within global pharmaceutical organizations, Viorel has contributed to the development, implementation, and oversight of quality systems supporting a diverse range of healthcare products, including sterile pharmaceuticals, radiopharmaceuticals, natural health products, dietary supplements, and medical devices. His professional focus centers on the application of science- and risk-based decision-making to quality and supply chain challenges, enabling organizations to maintain regulatory compliance while enhancing operational effectiveness.

Viorel has led numerous initiatives involving the integration of Quality Risk Management principles into GMP operations and quality decision-making processes. He has a particular interest in the intersection of product quality, supply chain resilience, regulatory compliance and business continuity, and is recognized for his pragmatic approach to addressing complex quality and operational challenges.

Prior to joining the pharmaceutical industry, Viorel conducted academic research in medicinal chemistry and authored scientific publications focused on the synthesis and characterization of cisplatin derivatives with potential antitumor activity.

Viorel holds a Master of Science in Chemistry from the Université du Québec à Montréal (UQAM), as well as Executive MBA degrees from the Université du Québec à Montréal and Université Paris Dauphine-PSL, France.